Data is not available at this time.
Emeis operates as a leading provider of healthcare services across Europe and select international markets, specializing in nursing homes, assisted-living facilities, post-acute rehabilitation, and psychiatric hospitals. The company generates revenue through a mix of private pay and government-funded healthcare contracts, leveraging its extensive network of facilities to deliver personalized care for elderly and specialized patient populations. Its diversified service offerings include accommodation, therapeutic workshops, and home care assistance, ensuring recurring revenue streams. Emeis holds a strong market position in France, where it was founded, and has expanded into Belgium, Spain, Italy, and beyond, capitalizing on aging demographics and increasing demand for long-term care. The company differentiates itself through integrated care models, combining medical expertise with residential services, which enhances patient outcomes and operational efficiency. Despite regulatory pressures in some markets, Emeis maintains a competitive edge through scale, geographic diversification, and a reputation for quality care. Its expansion into post-acute rehabilitation and psychiatric services further strengthens its resilience against sector-specific risks.
In FY 2023, Emeis reported revenue of €5.20 billion, reflecting its broad service footprint and stable demand for healthcare services. Net income stood at €1.35 billion, with diluted EPS of €130.59, indicating robust profitability. Operating cash flow was €366.1 million, though capital expenditures of €141.0 million suggest ongoing investments in facility maintenance and expansion. The company’s ability to convert revenue into earnings underscores its operational efficiency.
Emeis demonstrates strong earnings power, supported by high-margin specialized care services and government-backed reimbursement structures. The company’s capital efficiency is evident in its ability to sustain profitability despite significant debt levels, though leverage remains a focus area. Its asset-light model in home care services contributes to higher returns on invested capital compared to pure-play facility operators.
Emeis’s balance sheet shows €645.0 million in cash and equivalents against total debt of €9.16 billion, highlighting a leveraged position common in capital-intensive healthcare operators. The absence of dividends suggests prioritization of debt management and reinvestment. While the debt load is substantial, the company’s recurring revenue streams provide stability for servicing obligations.
Growth is driven by demographic trends favoring elderly care demand, with expansion into new markets like Latin America and China. Emeis does not currently pay dividends, opting to retain earnings for debt reduction and strategic acquisitions. Future growth may hinge on regulatory environments and the scalability of its home care segment.
With a market cap of €1.67 billion and a beta of 0.77, Emeis is viewed as a relatively stable investment within healthcare. The market appears to price in steady cash flows but remains cautious about leverage and regulatory risks. Valuation multiples likely reflect its niche positioning and long-term growth potential in aging societies.
Emeis benefits from geographic diversification, a diversified care portfolio, and entrenched relationships with public healthcare systems. Near-term challenges include managing debt and adapting to regulatory changes, but long-term demand for its services remains structurally supported. The company’s focus on integrated care models positions it well for sustainable growth.
Company description, financial data from disclosed filings, and market cap from exchange data.
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |